Chouaid C - Search Results

1

[An economic analysis of the management of bone metastases in lung cancer].

Decroisette C, Locher C, Iglesias E, Chouaid C; Groupe Français de Pneumo-Cancérologie (GFPC). Decroisette C, et al. Among authors: chouaid c. Rev Mal Respir. 2006 Nov;23(5 Pt 1):497-502. doi: 10.1016/s0761-8425(06)71826-5. Rev Mal Respir. 2006. PMID: 17314755 French.

2

[Epidemiology, management and cost of bone metastases from lung cancer].

Decroisette C, Galerneau LM, Hominal S, Chouaid C. Decroisette C, et al. Among authors: chouaid c. Rev Mal Respir. 2013 Apr;30(4):309-15. doi: 10.1016/j.rmr.2012.12.005. Epub 2013 Jan 11. Rev Mal Respir. 2013. PMID: 23664289 Review. French.

3

[The cost components of the management strategies for lung cancer in France].

Vergnenègre A, Molinier L, Combescure C, Daurès JP, Housset B, Chouaid C. Vergnenègre A, et al. Among authors: chouaid c. Rev Mal Respir. 2004 Jun;21(3 Pt 1):501-10. doi: 10.1016/s0761-8425(04)71354-6. Rev Mal Respir. 2004. PMID: 15292842 French.

4

[A prospective study of quality of life and treatment of chemotherapy-induced anaemia in lung cancer].

Borget I, Tilleul P, Baud M, Granghaud A, Iglesias E, Chouaid C. Borget I, et al. Among authors: chouaid c. Rev Mal Respir. 2007 Jan;24(1):41-7. Rev Mal Respir. 2007. PMID: 17268364 French.

5

[Stage IV NSCLC. Economic analysis in lung cancers].

Vergnenègre A, Atsou K, Molinier L, Chouaïd C. Vergnenègre A, et al. Among authors: chouaid c. Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S127-37. Rev Mal Respir. 2008. PMID: 18971837 Review. French.

6

[Comprehensive geriatric assessment and complications after resection for lung cancer].

Raynaud C, Le Caer H, Borget I, Jullian H, Locher C, Chouaid C; Groupe français de pneumocancérologie. Raynaud C, et al. Among authors: chouaid c. Rev Mal Respir. 2010 May;27(5):483-8. doi: 10.1016/j.rmr.2010.03.011. Rev Mal Respir. 2010. PMID: 20569881 French.

7

[Inhaled corticosteroids in asthma: a medico-economic analysis of clinical trials].

Vergnenègre A, Godard P, Atsou K, Chouaïd C. Vergnenègre A, et al. Among authors: chouaid c. Rev Mal Respir. 2008 Apr;25(4):375-89. doi: 10.1016/s0761-8425(08)71581-x. Rev Mal Respir. 2008. PMID: 18536625 Review. French.

8

Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC study.

Vergnenègre A, Monnet I, Chouaïd C, Hureaux J, Mazières J, Quéré G, Lombard JN, Cumin I, Abdiche S, Ejnaini CN, Bonnabau H, Decroisette Ch; GFPC team. Vergnenègre A, et al. Among authors: chouaid c. Lung Cancer. 2011 Nov;74(2):264-7. doi: 10.1016/j.lungcan.2011.03.007. Epub 2011 May 14. Lung Cancer. 2011. PMID: 21571389

9

[Evolution of the costs and management of lung cancer between 2004 and 2014].

Gadby F, Descourt R, Robinet G, Quere G, Gouva S, Roge C, Couturaud F, Chouaid C. Gadby F, et al. Among authors: chouaid c. Rev Mal Respir. 2020 Jan;37(1):1-7. doi: 10.1016/j.rmr.2019.10.010. Epub 2019 Dec 17. Rev Mal Respir. 2020. PMID: 31862137 French.

10

[Medical-economic evaluation of lung cancers. Theoretical approaches and practical applications].

Vergnenegre A, Chouaïd C, Lafuma A. Vergnenegre A, et al. Among authors: chouaid c. Rev Mal Respir. 1998 Sep;15(4):469-78. Rev Mal Respir. 1998. PMID: 9805757 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters